Danielle Harris PharmD, BCPS
Danielle Harris currently serves as the Acting Director and Deputy Director of the Division of Medication Error Prevention and Analysis II in the Office of Surveillance and Epidemiology (OSE) at FDA. With 15 years of medication safety experience, she provides oversight of the pre- and post-marketing safety activities related to drug nomenclature, labels and labeling, packaging, and product design for drug and therapeutic biologic products regulated by the Center for Drug Evaluation and Research (CDER) at FDA. She also participates in Agency guidance and policy development in the area of medication error prevention and drug nomenclature. Dr. Harris earned her Doctor of Pharmacy degree from Northeastern University and completed a Pharmacy Practice Residency at Beth Israel Deaconess Medical Center in Boston, Massachusetts.